Background-The role of adaptive immunity, especially CD4 ϩ T-helper cells, has not yet been systematically investigated in wound healing and remodeling after myocardial infarction (MI). Therefore, we studied whether CD4 ϩ T cells become activated and influence wound healing after experimental MI in mice.
I schemic heart disease develops from a single large or from recurrent small myocardial infarctions (MIs) and is the major cause of heart failure. Today, standard therapy of acute MI is prompt reperfusion by balloon catheter-facilitated vessel dilation or pharmacological thrombus lysis. However, if reperfusion is established too late, a large transmural infarction may develop. Despite standardized therapy, prognosis remains poor in these patients, who regularly display severe left ventricular (LV) dysfunction after MI. 1 Thus, it would be highly desirable to develop new therapeutic options to improve healing after MI.
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Myocardial injury induces a massive infiltration of innate immune cells into the infarct border zone starting within a few hours after the onset of ischemia in the mouse model. [2] [3] [4] Granulocytes and monocytes/macrophages have long been recognized as the main innate effector cells that modulate myocardial healing; however, the detailed mechanisms that control recruitment, differentiation, and effector function of these heart-infiltrating cells have not been defined comprehensively.
The possible contribution of adaptive immunity in this context has been widely disregarded, probably for 2 main reasons. First, infiltration of lymphocytes into the infarcted myocardium is rare, and is therefore often not monitored in experimental studies. Second, at first glance, activation of lymphocytes contradicts the classic notion that adaptive immunity is not stimulated by self-antigens. However, there are several findings from both clinical and experimental animal studies that implicate the activation of cells of the adaptive immune system after MI. Maisel et al, 5 for example, reported that ex vivo activated splenocytes collected from rats after experimental MI infiltrated the myocardium of noninfarcted recipient animals. Splenocytes from infarcted rats contain a subset of CD8 ϩ T lymphocytes with cytotoxic activity against cardiomyocytes ex vivo. 6 Another line of evidence comes from experimental autoimmune myocarditis models that demonstrated that T cells specific for myocardial proteins do exist in mice. Here, both immunization with troponin-or myosin-derived peptides and transfer of myosin peptide-loaded dendritic cells induced myocarditis in susceptible mouse strains. 7, 8 In patients with known coronary heart disease, the prevalence of antibodies to contractile proteins is increased. 9 Because B-cell production of antibodies that recognize protein antigens normally requires the concomitant activation of CD4 ϩ helper T cells, this observation indirectly implies that CD4 ϩ T cells that can be activated by autoantigens released during ischemic heart injury also exist in humans. Accordingly, Cheng et al 10 reported activation of circulating T lymphocytes with a Th1/Th2 functional imbalance toward Th1 in patients with acute MI. Moreover, Abbate et al 11 demonstrated infiltration of lymphocytes into infarcted and remote myocardium of patients with MI. However, the contribution of CD4 ϩ T-lymphocyte subsets to and the relevance of CD4 ϩ T-cell activation for myocardial wound healing and remodeling have not yet been studied systematically.
These observations prompted us to hypothesize that CD4 ϩ T cells might become activated after ischemic injury of the heart and influence myocardial wound healing. The results of our study indicate that both conventional and Foxp3 ϩ regulatory CD4 ϩ T cells 12 are activated in the wake of MI and that CD4 ϩ T-cell activation beneficially influences wound healing and survival.
Methods

Animals
Animals were maintained for at least 2 weeks to acclimatize them to a 12-hour/12-hour light/dark cycle, with free access to standard diet and water. All mice were kept under specific pathogen-free conditions. Eight-to 10-week-old male C57BL/6J mice (stock No. 000664), CD4 knockout (KO) mice (stock No. 002663), OT-II mice (stock No. 004194), mice lacking all 4 of the major histocompatibility class II genes (MHCII ⌬/⌬ mice; stock No. 003584), and CD4 -enhanced green fluorescent protein (EGFP) mice (stock No. 005334) were purchased from The Jackson Laboratory (Bar Harbor, ME).
This investigation conformed to the "Guide for the Care and Use of Laboratory Animals" published by the US National Institutes of Health. All animal procedures were approved by the local government (reference No. 01/08, 90/10).
Infarct Model
MI was induced in mice as described previously. 13 In brief, mice were anesthetized with isoflurane, intubated, and put on a mechanical small-animal ventilator. After a left-sided thoracotomy was performed, MI was induced by ligating the proximal portion of the left coronary artery. Buprenorphine was given intraperitoneally for perioperative analgesia. In parallel subgroups, a thoracotomy was performed to expose the heart, but no suture was made to the coronary artery (sham operation).
Echocardiography
Echocardiography was performed on a Toshiba Aplio system with a 15-MHz ultrasound probe with the mice under light anesthesia with isoflurane (Ϸ1.5 vol%) and spontaneous respiration. 13
Fluorescence-Activated Cell Sorter Analysis
Cell suspensions from individual hearts were prepared by digestion with collagenase type 2 and protease type XIV (Sigma-Aldrich, Munich, Germany), as described in detail recently. 14 Staining protocols were described recently 15 and are further specified in the online-only Data Supplement. For antibodies used, see online-only Data Supplement Table I .
In Vitro Proliferation Assay
Single-cell suspensions from lymph nodes and spleens were prepared with a 70-m cell strainer (BD Falcon, Heidelberg, Germany). Spleen cell suspensions were further subjected to hypo-osmotic shock for erythrocyte depletion.
Proliferation/antigen recall assays were performed in 96-well U-bottom plates. A total of 2ϫ10 5 
Light Microscopy
Sections of mouse myocardium were fixed in 4% paraformaldehyde overnight and embedded in paraffin. Five-micrometer sections were stained according to standard hematoxylin-and-eosin and Ladewig staining protocols; for determination of infarct size, collagen was stained by picrosirius red on 7-m sections, as described recently. 13 Immunohistochemistry for neutrophils, endothelial cells (CD31), collagen-expressing cells (P4HB), and smooth muscle actin was performed on 5-m paraffin sections; immunohistochemistry for macrophages/monocytes was performed on 5-m cryostat sections. Protocols and antibodies are specified in the online-only Data Supplement.
we injected fluorescent microparticles into the anterior LV free wall during infarct surgery to identify heart-draining lymph nodes. These microparticles are designed to be readily incorporated by phagocytosing cells. Fluorescence-activated cell sorter (FACS) analysis 16 hours after MI surgery revealed labeled microparticles in CD11b ϩ cells isolated from infarcted myocardium and in cells from lymph nodes of the right upper mediastinum but not in cervical or inguinal lymph nodes, spleen, or bone marrow (online-only Data Supplement Figure I ). These mediastinal lymph nodes were consistently enlarged after MI but not after sham surgery. In wild-type (WT) mice, the total cell number in these lymph nodes was significantly greater than in sham-operated or naive (not operated) mice 7 days after MI (5.4Ϯ0.8ϫ10 6 in WT MI mice, 1.1Ϯ0.4ϫ10 6 in WT sham-operated mice, and 0.4Ϯ0.0ϫ10 6 in naive mice; PϽ0.05; Figure 1A ). These data provided a first indication that there was an activation process specifically induced by myocardial injury and not merely by the surgical procedure (sham surgery).
Next, we cultured freshly isolated cells from mediastinal lymph nodes of mice with MI or after sham treatment in vitro and determined their spontaneous proliferative activity by measuring ( 3 H)-thymidine incorporation. We found that the basal proliferative activity was significantly higher in animals with MI than in sham animals, both 7 days (3.7Ϯ0.4ϫ10 6 cpm for sham surgery versus 5.4Ϯ1.1ϫ10 6 cpm for MI; PϽ0.05) and 21 days (0.07Ϯ0.01ϫ10 6 cpm for sham surgery versus 0.13Ϯ0.03ϫ10 6 cpm for MI; PϽ0.05) after MI. This suggests that the increased cellularity we observed in vivo was probably caused by cell proliferation in lymph nodes in response to MI.
To further confirm that T cells proliferate in vivo in response to MI in heart-draining lymph nodes, we directly analyzed expression of the proliferation marker Ki67 by CD4 ϩ T cells isolated from mediastinal lymph nodes on day 7 after MI. As shown in Figure 1B , a significantly higher proportion of CD4 ϩ T cells were positive for the proliferation marker Ki67 after MI than in sham-operated animals. Thus, we could demonstrate that MI induces proliferation of CD4 ϩ T cells in heart-draining lymph nodes in vivo. 
Distribution and Differentiation of CD4 ؉ T Cells Within the Myocardium After MI
After having demonstrated that MI induces proliferation of CD4 ϩ T cells in heart-draining lymph nodes, we investigated whether T cells invade the infarcted myocardium. Determination of the absolute numbers of myocardial CD3 ϩ CD4 ϩ T cells, as identified by FACS analysis, revealed recruitment to the infarct zone by day 7 after MI ( Figure 1C ). We further used a transgenic mouse model that expressed EGFP under the murine CD4 promoter for regional assessment of T-cell distribution in myocardium by immunohistology. On day 3, CD4 ϩ T cells could be detected by anti-EGFP staining in immunohistology within the infarct/infarct border zone, whereas CD4 ϩ T cells were hardly detectable in the myocardium of naive/sham-operated mice (data not shown). By day 5, EGFP ϩ T cells were evenly distributed in infarcted and noninfarcted LV myocardium ( Figure 1D ). The frequency of EGFP ϩ T cells then decreased within the infarct/infarct border zone until day 21, whereas it did not change within the septum. However, even at the peak of intracardiac CD4 ϩ T-cell accumulation, the prevalence of CD4 ϩ T cells remained low and accounted for Ͻ1% of all cells, including cardiomyocytes, as determined by FACS analysis on day 7 (data not shown).
Despite their paucity, intracardiac CD4 ϩ T cells might play an important role in wound healing. Therefore, we analyzed their differentiation state by FACS analysis of intracellular cytokines. We detected intracellular expression of interleukin-10 (IL-10), IL-17, and interferon-␥ (IFN-␥; Figure 1E ). IFN-␥ was the most abundantly expressed cytokine in CD4 ϩ T cells from both sham and MI hearts. The expression level (mean fluorescent intensity) of IFN-␥ was significantly higher in CD4 ϩ T cells derived from infarcted than from sham-operated myocardium. The mean fluorescent intensity of IL-17 and IL-10 was not increased after MI. Although there was no significant increase in the individual relative frequencies of cytokine-expressing cells among CD4 ϩ T cells from sham versus MI hearts, the recruitment of CD4 ϩ T cells ( Figure 1C ) resulted in a significant net increase in cytokine-producing T cells. Collectively, these data indicate that MI induced an overall increase of cytokineproducing CD4 ϩ T cells within both infarcted and remote myocardium.
Increased LV Dilation and Disturbed Scar Formation in CD4 ؉ T-Cell-Deficient Mice
To gain insight into the functional role of CD4 ϩ T cells for wound healing after MI, we performed permanent coronary artery ligation in CD4 KO animals, which lack CD4 ϩ T cells. Baseline LV function and geometry were not different in CD4 KO and WT animals. Cumulative survival, infarct size, heart and lung weights, and papillary echocardiographic parameters (Table 1) were also not different up to day 56 after MI. However, there was a significantly greater enlargement of the LV area determined at the apical level, which represented the infarct zone, over time (day 56 apical end-diastolic area, 42.2Ϯ1.6 mm 2 in CD4 KO mice versus 34.7Ϯ6.6 mm 2 in WT mice; PϽ0.05; Figure 2A ). Histology of the infarct zone demonstrated qualitative and quantitative differences in the collagen composition of the scars. Ladewig collagen staining revealed disarrayed collagen fiber alignment within the infarct zone in CD4 KO mice on day 7 ( Figure 3A ). Quantification of extracellular collagen content based on picrosirius red-stained sections revealed significantly lower amounts in CD4 KO than in WT mice ( Figure 3C ).
In summary, the absence of CD4 ϩ T cells led to increased early LV dilation without affecting mortality. This was accompanied by disturbed collagen de novo formation within the infarct zone.
CD4 ؉ T Cells Modulate Recruitment of Innate Immune Cells to the Infarcted Heart
Neutrophils and monocytes infiltrating the infarcted myocardium critically modulate myocardial wound healing. Therefore, we studied whether CD4 ϩ T cells modulate innate immune cell recruitment to the infarcted myocardium. Immunohistology showed a greater density of both granulocytes and monocytes/macrophages within the infarcted myocardium of CD4 KO compared with WT mice on day 7 ( Figures  4A and 4B ). Because CD11b ϩ granulocytes and monocytes/ macrophages represent the main leukocyte subsets infiltrating the infarct zone within the first week after MI, these cells were studied further by FACS analysis. Granulocytes were defined as CD11b ϩ GR1/Ly6G ϩ and monocytes/macrophages as CD11b ϩ GR1/Ly6G Ϫ (online-only Data Supplement Figure II ). There was no difference in leukocyte density or innate leukocyte subset composition between WT and CD4 KO mice on day 3 (data not shown). On day 7, leukocyte density in the infarct/infarct border zone was significantly higher in CD4 KO than in WT mice ( Figure 4C ), which reflects a parallel increase in both neutrophils and monocytes/ macrophages on day 7 (data not shown). Analysis of the monocyte differentiation marker Ly6C in the CD11b ϩ GR1/ Ly6G Ϫ subset revealed that in CD4 KO mice, a significantly higher proportion consisted of proinflammatory Ly6C high monocytes (34.0Ϯ6.0% versus 20.1Ϯ1.6% in WT mice; PϽ0.05; Figure 4D ) on day 7. Ly6C high monocytes are preferentially recruited during the first 3 to 5 days by the chemokine monocyte chemotactic protein-1. Accordingly, monocyte chemotactic protein 1 expression was significantly higher in the infarct/infarct border zone of CD4 KO mice (246.2Ϯ54.1 pg/mg in CD4 KO mice versus 81.0Ϯ17.8 pg/mg in WT mice; PϽ0.05; Figure 4E ).
Moreover, the frequency of apoptosis, as analyzed by annexin V and propidium iodide staining of CD11b ϩ leuko- cytes, was not different between genotypes on day 7 (data not shown). Because intramyocardial monocyte proliferation is marginal, 16 differential recruitment is most likely the main mechanism for the observed differences in monocyte subset composition. Because MMP-9 is the main matrix metalloproteinase (MMP) secreted by infiltrating leukocytes during the first days after MI, and because MMP activity is associated with adverse LV remodeling and dysfunctional wound healing, 17 we analyzed intracellular MMP-9 expression in CD11b ϩ cells derived from the infarct/infarct border zone by FACS analysis. Single-cell MMP-9 expression (mean fluorescent intensity of the MMP-9 ϩ subset) was significantly higher in CD4 KO than in WT mice (mean fluorescent intensity, 277.5Ϯ66.1 versus 48.5Ϯ0.4 in WT mice; PϽ0.05; Figure 4F ).
To elucidate whether CD4 ϩ T cells affect the cytokine/ chemokine milieu within the infarct zone, we assessed their relative expression in CD4 KO and WT mice by means of quantitative PCR arrays. In general, expression of proinflammatory and anti-inflammatory cytokines and chemokines and their receptors revealed a complex pattern of expression. For example, both the relative mRNA and protein expression of the prototypical CD4 ϩ T-cell-derived anti-inflammatory and proinflammatory cytokines IL-10 and IFN-␥ were reduced in CD4 KO MIs (online-only Data Supplement Table III ; Figure  4G ), which is also in accordance with our data showing expression of both cytokines in intramyocardial CD4 ϩ T cells ( Figure 1E) .
Collectively, the absence of CD4 ϩ T cells resulted in an increased density of innate immune cells (granulocytes and monocytes/macrophages), with a higher prevalence of proinflammatory monocytes on day 7.
Higher Mortality in CD4 ؉ T-Cell-Deficient MHCII ⌬/⌬ Mice
Because there is a subset of MHC class II-restricted CD8 ϩ T cells in the CD4 KO mouse that can, at least in part, functionally compensate for the lack of CD4 ϩ T cells, 18 we additionally studied class II MHC-deficient MHCII ⌬/⌬ mice. In MHCII ⌬/⌬ mice, there is a nearly complete absence of CD4 ϩ T cells, with normal development of the CD8 ϩ T-cell compartment. 19 MHCII ⌬/⌬ mice showed significantly impaired survival compared with WT animals ( Figure 2B ). By day 7, mortality was 21% in WT and 48% in MHCII ⌬/⌬ mice (4 of 19 WT versus 10 of 21 MHCII ⌬/⌬ mice). Unlike CD4 KO mice, there was no enhanced LV dilatation after MI ( Table 2) . Infarct size was also not different between genotypes. Analogous to the findings in the CD4 KO model, there was a trend toward a higher prevalence of proinflammatory monocytes in MHCII ⌬/⌬ mice on day 8 (7.3Ϯ1.1% in MHCII ⌬/⌬ versus 3.8Ϯ1.0% in WT mice; Pϭ0.08; nϭ4 -5 per group).
Formation of Collagenous Scar Is Disturbed in CD4 ؉ T-Cell-Deficient Mice
Extracellular matrix cleavage, de novo formation, and angiogenesis are hallmarks of granulation tissue formation during early wound healing. The common feature of the infarct zone of CD4 ϩ T-cell-deficient CD4 KO and MHCII ⌬/⌬ mice was fewer and disarrayed collagen fibers within the infarct zone compared with WT mice (Figure 3 ). This was not accompanied by a reduced frequency of collagen-producing cells within the infarct zone ( Figure 5A ). Accordingly, analysis of collagen I de novo expression by reverse transcriptase-PCR revealed no differences between WT and CD4 KO mice after MI ( Figure 5B ).
Besides collagen de novo synthesis, the collagenolytic activity of matrix metalloproteinases determines extracellular collagen composition. However, there was also no difference in total collagenolytic activity between WT and CD4 KO mice, which argues against a role of matrix degradation in the disturbed collagenous scar composition ( Figure 5C ).
Immunohistology for the endothelial cell surface marker CD31 demonstrated that capillary density, which reflects angiogenesis, within the infarct border zone of CD4 KO mice was lower than in WT mice ( Figure 5D ). Collectively, these data indicate that the absence of CD4 ϩ T cells impairs collagen matrix de novo formation and angiogenesis without influencing collagen breakdown.
Increased Mortality and Myocardial Rupture in OT-II Mice
To assess whether the mere absence of CD4 ϩ T cells or lack of antigen recognition by the CD4 ϩ T cells accounted for the observed differences between WT and CD4 ϩ T-cell-deficient mice, we further studied OT-II mice. The majority of CD4 ϩ T cells in OT-II mice exclusively recognize an irrelevant ovalbumin-derived peptide via their T-cell receptor. Baseline echocardiographic geometry and function were not different between genotypes. Fifty-six days after permanent MI, infarct size, heart weight to body weight ratio, and lung weight to body weight ratio were not different from WT mice ( Table 3) . OT-II mice, however, showed significantly impaired survival compared with WT animals ( Figure 6A ). Cumulative 56-day mortality was 23% (WT, 10 of 44) versus 51% (OT-II, 20 of 39). In both groups, most animals died within the first week of heart failure or ventricular ruptures, but the incidence of LV ruptures in mice with MI was significantly higher in OT-II (19%) than in WT (3%) mice. Hence, the increased early mortality in OT-II mice indicates that an intact T-cell receptor repertoire is vital for the protective function of CD4 ϩ T cells after MI.
Immunohistology revealed no difference in granulocyte and monocyte/macrophage density within the infarct zone on day 7 (data not shown). Because the day 7 data might be biased by differential survival, we further analyzed inflammatory cell infiltration on day 3. FACS analysis of infiltrating innate immune cells within the infarct zone on both days 3 and 7 revealed no differences between OT-II and WT (online-only Data Supplement Table II) .
Similar to CD4 ϩ T-cell-deficient mice, collagen fibers within the infarct zones in OT-II mice were more loosely distributed and disarrayed on day 7. As in CD4 KO and MHCII ⌬/⌬ mice, total extracellular collagen density within the infarct zone was less in OT-II than in WT mice ( Figure  6C ). PCR analysis revealed no difference in collagen I or III and MMP or tissue inhibitor of metalloproteinase expression between OT-II and WT mice (data not shown).
Collectively, as in the CD4 ϩ T-cell-deficient mice, OT-II mice demonstrated impaired wound healing, which was associated with increased early mortality. 
Antigen Recognition Is Vital for Early CD4 ؉ T-Cell Activation After MI
After having demonstrated that the mere presence of CD4 ϩ T cells was not sufficient and that antigen recognition via the T-cell receptor appeared to be a prerequisite for proper wound healing, we next studied the activation of conventional Foxp3 Ϫ and regulatory Foxp3 ϩ CD4 ϩ T cells in heartdraining lymph nodes of WT and OT-II mice. Because the differences in clinical outcome between WT and CD4 KO or MHCII ⌬/⌬ mice, as well as OT-II mice, were already evident within the first 7 days, we also studied CD4 ϩ T-cell activation during the first week after MI. In particular, we analyzed expression of the activation marker CD25 on conventional Foxp3 Ϫ CD4 ϩ T cells on day 3 after MI or sham operation ( Figure 7A ). WT but not OT-II mice showed significantly increased frequencies of CD25 ϩ cells among conventional T cells after MI (Figures 7A and 7C) . Moreover, absolute cell numbers of conventional CD4 ϩ T cells, expressed as the ratio of MI over sham ( Figure 7D ), tended to be increased in WT but not OT-II mice. Early antigen-dependent activation, however, did not appear to be restricted to conventional CD4 ϩ T cells but was probably even greater in Foxp3 ϩ regulatory T cells (Tregs), because their proportion among all CD4 ϩ T cells in mediastinal lymph nodes of WT mice was increased significantly on day 3 (Figures 7B and 7C) . Concomitantly, the ratio of the absolute cell numbers of Tregs from WT mice increased significantly after MI ( Figure 7E ). However, in contrast to day 7 (data not shown), on day 3 neither CD4 ϩ Foxp3 Ϫ nor CD4 ϩ Foxp3 ϩ cells showed increased frequencies of proliferating Ki67-expressing cells (data not shown).
Collectively, the data indicate that in WT mice, MI and the ensuing release of cardiac antigens impacts on both conventional, putatively autoreactive CD4 ϩ T cells and Tregs, the autoreactivity of which is well documented. T-cell receptor activation in WT mice induced both early expansion of Tregs and activation of conventional CD4 ϩ T cells. The increase in Treg frequencies among CD4 ϩ T cells observed on day 3 after MI, however, did not prevent subsequent CD4 ϩ T-cell proliferation ( Figure 1B) and infiltration of CD4 ϩ T cells into the myocardium (Figure 1C ).
Discussion
The present study provides the first evidence that CD4 ϩ T cells are activated and beneficially modulate myocardial wound healing after experimental MI. There are several reports from clinical studies indicating that cells of the adaptive immune system, especially T lymphocytes, become activated in patients with coronary artery disease or a history of MI. 9, 11, 20 However, it is important to remember that components of activated plaques, which typically trigger coronary artery thrombus formation that leads to MI, also activate T lymphocytes. 21 Therefore, analysis of lymphocyte activation, especially when lymphocytes are derived from peripheral blood of humans, does not allow the distinguishing of coronary artery from myocardial inflammation. The mouse model of MI in which MI is induced by ligature of a coronary vessel uniquely enables the study of whether adaptive immunity is activated by cardiac injury, without possible interfering effects from coronary artery inflammation/atherosclerosis. There is further recent evidence from studies in the mouse myocardial ischemia-reperfusion model that CD4 ϩ T cells modulate ischemia-reperfusion injury. 22, 23 However, it is important to emphasize that the present study was conducted to study the role of CD4 ϩ T cells in wound healing and remodeling. Therefore, all experiments were performed in a model of permanent ischemia to obviate any possible effects of CD4 ϩ T cells on primary infarct size.
Classic activation of T cells requires the presentation of antigens by antigen-presenting cells (dendritic cells, macrophages, B cells) to the T-cell receptor, which typically takes place in the draining lymph nodes of the organ. We hypothesize that myocardial antigens that are normally not accessible to the immune system or neoantigens created during ischemic injury (eg, by oxidative modifications) are released from the myocardium, become phagocytosed, and are presented to CD4 ϩ T cells. Monocytes infiltrate the injured myocardium 16 and can differentiate into macrophages and dendritic cells, which can also be found within the infarcted myocardium. 24 Both cell types are able to present antigens on MHC-II complexes to CD4 ϩ T cells. By means of intramyocardial injection of labeled particles, we could identify heart-draining mediastinal lymph nodes. Within these lymph nodes, we were able to demonstrate that MI specifically induces activation and proliferation of CD4 ϩ T cells.
The functional role of CD4 ϩ T-cell activation was therefore studied in vivo in independent animal models that either lacked CD4 ϩ T cells (CD4 KO and MHCII ⌬/⌬ mice) or expressed a transgenic T-cell receptor specific for an ovalbumin-derived peptide (OT-II mice), which led to strongly reduced reactivity toward other antigens, including selfantigens. All mouse models demonstrated dysfunctional wound healing during the first week after MI, which was histologically most evident as extracellular matrix disarray within the infarct zone. The OT-II and MHCII ⌬/⌬ models showed a more pronounced phenotype, because survival was significantly worse and the LV rupture rate was increased, whereas in the CD4 KO model, aggravated LV dilation was not associated with increased mortality. The differences in the 2 phenotypes most likely results from the presence of a considerable population of MHC-II-restricted CD8 ϩ T cells in the CD4 KO model, which can, at least in part, functionally compensate for the lack of CD4 ϩ T cells. 18 This consideration in turn further emphasizes the importance of MHC-IIrestricted antigen recognition for the observed effects.
The phenotype of the OT-II model demonstrates that an antigen-specific activation of CD4 ϩ T cells rather than their mere presence is necessary for proper wound healing in WT mice. This finding differs from the recently demonstrated detrimental effects of T cells in a mouse model of cerebral ischemia-reperfusion injury, in which the impact of T cells on the clinical phenotype was shown to be unrelated to antigen recognition via the T-cell receptor. 25 Therefore, in contrast to cerebral ischemia-reperfusion, one might speculate that after MI, an antigen-specific immunomodulation therapy might be successful in humans.
However, for translation of the present data derived from young male mice into the clinic, the effect of sex and age deserves further investigation. Comparative data from male and female aged animals after MI are widely lacking. However, it has been demonstrated that in old mice, there is reduced inflammation but enhanced LV remodeling and impaired preservation of systolic function compared with young mice. 26 Immunosenescence has also been described for T-cell responses. 27 Therefore, impaired activation of T cells by myocardial antigens might contribute to the worse outcome in aged mice and humans after MI.
For an exact understanding of the role of the adaptive immune system in cardiac wound healing, it remains to be determined where and how CD4 ϩ T cells exert their beneficial effects. One could hypothesize that heart-infiltrating CD4 ϩ T cells modulate the local cytokine/chemokine milieu and thus influence recruitment and activation of innate immune cells. Correspondingly, we found a greater leukocyte infiltrate and a higher proportion of proinflammatory Ly6C ϩ monocytes in CD4 KO myocardium. It has been demonstrated that timely recruitment of the different monocyte subsets, which can be characterized by expression of the surface molecule Ly6C, is a prerequisite for proper myocardial wound healing. 16 However, a prolonged proinflammatory monocyte infiltration was only observed in CD4 ϩ T-cell-deficient mice, which rules out monocytes as the key effectors inducing the impaired collagen de novo synthesis that we observed in all 3 models. Rather, the present results suggest that heartinfiltrating CD4 ϩ T cells might directly modulate the function of collagen-secreting cells. Both CD4 ϩ T-cell-deficient mice (CD4 KO and MHCII ⌬/⌬ ) and OT-II mice demonstrated disarrayed collagen fibers within the de novo formed collagenous scar. Neither the parameters of collagen de novo formation (collagen-producing cell density, collagen expression) nor total matrix proteinase expression and activity were changed in CD4 KO and OT-II compared with WT mice. Thus, most likely, impaired posttranscriptional processing of matrix proteins accounts for the observed phenotype. Several anti-inflammatory T-cell-derived cytokines, such as IL-10 28 and IL-13, 29 have been demonstrated to influence extracellular matrix formation by modification of (myo)fibroblast differentiation and proliferation in various disease models. We found that both cytokines were downregulated in CD4 KO mice after MI. Although we cannot provide definitive experimental evidence, those CD4 ϩ T-cell-derived cytokines are potential mediators linking CD4 ϩ T-cell activation and extracellular collagen synthesis in myocardial wound healing.
Moreover, although monocytes/macrophages are welldescribed effectors in wound healing and remodeling after MI, the present data now point to CD4 ϩ T cells as additional players that either directly or indirectly influence these processes.
Apart from CD4 ϩ T cells, we also observed increased proliferation of CD8 ϩ T cells 7 days after MI (data not shown). Preliminary data further show that this was not the case in MHCII ⌬/⌬ mice, which suggests that class II MHCrestricted CD4 ϩ T cells are needed for CD8 ϩ T cells to become activated after MI. Because the activation of CD8 ϩ T cells in WT mice may influence wound healing, it cannot be totally excluded that the altered proportion of CD8 ϩ T cells in both CD4-deficient and OT-II mice compared with WT mice might have contributed to the phenotypes observed in these mutants.
Whereas conventional CD4 ϩ T cells often exert their biological effects after proinflammatory differentiation (eg, Th1, Th17), many of the effects of regulatory T cells can be attributed to the expression of anti-inflammatory cytokines. In particular, so-called natural regulatory T cells are well known for preventing autoimmunity. 12 We could demonstrate an early relative increase in the frequencies of these CD4 ϩ Foxp3 ϩ Tregs among all CD4 ϩ T cells in heart-draining lymph nodes as early as 3 days after MI. This early shift toward higher regulatory T-cell frequencies was only seen in WT and not in OT-II mice, which indicates that antigens released during MI induce an early response of conventional T cells and even more so of Tregs. The observation that Treg frequencies were increased in the absence of overt changes in proliferative activity, as indicated by frequencies of Ki67 ϩ cells on day 3 after MI, suggests either that Tregs are selectively recruited to or retained in mediastinal lymph nodes in WT mice or, alternatively, that they might have proliferated earlier. This CD4 ϩ T-cell response triggered by MI in heart-draining lymph nodes is strikingly similar to that observed after immunization of mice with complete Freund's adjuvant that contained foreign antigens. 30 Tregs are also concomitantly activated with conventional CD4 ϩ T cells in a mouse model of mucosal herpes simplex infection, in which they play a crucial role in fine-tuning the immune response, thereby allowing for resolution of the infection. 31 In accordance with the similarity of the early CD4 ϩ T-cell activation pattern that we observed after MI to that triggered by foreign antigens, 32 it was demonstrated very recently that both in mice and in humans, the cardiomyocyte-specific protein ␣-myosin heavy chain at least partially resembles a foreign antigen, because it is not expressed within the thymus. 30 In autoimmune myocarditis, release of ␣-myosin heavy chain leads to CD4 ϩ T-cell activation, which essentially contributes to the disease pathology, because its expression in the thymus abolished the development of myocarditis in mice. It was further demonstrated that not only does the peripheral T-cell compartment of mice harbor ␣-myosin heavy chain-reactive T cells, but there are also CD4 ϩ T cells reactive to troponin. 23 Thus, it appears that several myocardial proteins released during MI are not negatively selected against in the thymus, and therefore, when released by cardiac injury, they evoke a CD4 ϩ T-cell response similar to that toward a non-self-antigen. In the setting of MI, this coordinate activation process of conventional and regulatory T cells obviously does not lead to detrimental autoimmunity, as in the case of myocarditis, but appears to tune the immune response, ultimately promoting resolution of inflammation and wound healing.
Taken together, we have demonstrated for the first time that activation of CD4 ϩ T cells is a prerequisite for proper wound healing and subsequent remodeling of the myocardium after MI. These findings may thus pave the way for the identification of novel therapeutic targets to improve clinical outcome in patients with MI.
